The global Liquid Biopsy IVD market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Liquid Biopsy IVD is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Liquid Biopsy IVD is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Liquid Biopsy IVD is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Liquid Biopsy IVD players cover Bio-Rad, Roche, Biocartis, Qiagen, Guardant Health, MDxHealth, OME Care, NeoGenomics Laboraories and Sysmex Inostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue, known as circulating tumor (ct) DNA.
LPI (LP Information)' newest research report, the “Liquid Biopsy IVD Industry Forecast” looks at past sales and reviews total world Liquid Biopsy IVD sales in 2022, providing a comprehensive analysis by region and market sector of projected Liquid Biopsy IVD sales for 2023 through 2029. With Liquid Biopsy IVD sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liquid Biopsy IVD industry.
This Insight Report provides a comprehensive analysis of the global Liquid Biopsy IVD landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liquid Biopsy IVD portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Liquid Biopsy IVD market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liquid Biopsy IVD and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liquid Biopsy IVD.
This report presents a comprehensive overview, market shares, and growth opportunities of Liquid Biopsy IVD market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Circulating Tumor Cells
Circulating Tumor DNA
Extracellular Vesicles
Others
Segmentation by application
Blood Sample Based
Urine Sample Based
Other Bio Fluids Based
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Rad
Roche
Biocartis
Qiagen
Guardant Health
MDxHealth
OME Care
NeoGenomics Laboraories
Sysmex Inostics
Menarini Silicon Biosystems
Adaptive Biotechnologies
Biocept
Angle plc

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Liquid Biopsy IVD Market Size 2018-2029 2.1.2 Liquid Biopsy IVD Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 Liquid Biopsy IVD Segment by Type 2.2.1 Circulating Tumor Cells 2.2.2 Circulating Tumor DNA 2.2.3 Extracellular Vesicles 2.2.4 Others 2.3 Liquid Biopsy IVD Market Size by Type 2.3.1 Liquid Biopsy IVD Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global Liquid Biopsy IVD Market Size Market Share by Type (2018-2023) 2.4 Liquid Biopsy IVD Segment by Application 2.4.1 Blood Sample Based 2.4.2 Urine Sample Based 2.4.3 Other Bio Fluids Based 2.5 Liquid Biopsy IVD Market Size by Application 2.5.1 Liquid Biopsy IVD Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global Liquid Biopsy IVD Market Size Market Share by Application (2018-2023) 3 Liquid Biopsy IVD Market Size by Player 3.1 Liquid Biopsy IVD Market Size Market Share by Players 3.1.1 Global Liquid Biopsy IVD Revenue by Players (2018-2023) 3.1.2 Global Liquid Biopsy IVD Revenue Market Share by Players (2018-2023) 3.2 Global Liquid Biopsy IVD Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Liquid Biopsy IVD by Regions 4.1 Liquid Biopsy IVD Market Size by Regions (2018-2023) 4.2 Americas Liquid Biopsy IVD Market Size Growth (2018-2023) 4.3 APAC Liquid Biopsy IVD Market Size Growth (2018-2023) 4.4 Europe Liquid Biopsy IVD Market Size Growth (2018-2023) 4.5 Middle East & Africa Liquid Biopsy IVD Market Size Growth (2018-2023) 5 Americas 5.1 Americas Liquid Biopsy IVD Market Size by Country (2018-2023) 5.2 Americas Liquid Biopsy IVD Market Size by Type (2018-2023) 5.3 Americas Liquid Biopsy IVD Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Liquid Biopsy IVD Market Size by Region (2018-2023) 6.2 APAC Liquid Biopsy IVD Market Size by Type (2018-2023) 6.3 APAC Liquid Biopsy IVD Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Liquid Biopsy IVD by Country (2018-2023) 7.2 Europe Liquid Biopsy IVD Market Size by Type (2018-2023) 7.3 Europe Liquid Biopsy IVD Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Liquid Biopsy IVD by Region (2018-2023) 8.2 Middle East & Africa Liquid Biopsy IVD Market Size by Type (2018-2023) 8.3 Middle East & Africa Liquid Biopsy IVD Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Liquid Biopsy IVD Market Forecast 10.1 Global Liquid Biopsy IVD Forecast by Regions (2024-2029) 10.1.1 Global Liquid Biopsy IVD Forecast by Regions (2024-2029) 10.1.2 Americas Liquid Biopsy IVD Forecast 10.1.3 APAC Liquid Biopsy IVD Forecast 10.1.4 Europe Liquid Biopsy IVD Forecast 10.1.5 Middle East & Africa Liquid Biopsy IVD Forecast 10.2 Americas Liquid Biopsy IVD Forecast by Country (2024-2029) 10.2.1 United States Liquid Biopsy IVD Market Forecast 10.2.2 Canada Liquid Biopsy IVD Market Forecast 10.2.3 Mexico Liquid Biopsy IVD Market Forecast 10.2.4 Brazil Liquid Biopsy IVD Market Forecast 10.3 APAC Liquid Biopsy IVD Forecast by Region (2024-2029) 10.3.1 China Liquid Biopsy IVD Market Forecast 10.3.2 Japan Liquid Biopsy IVD Market Forecast 10.3.3 Korea Liquid Biopsy IVD Market Forecast 10.3.4 Southeast Asia Liquid Biopsy IVD Market Forecast 10.3.5 India Liquid Biopsy IVD Market Forecast 10.3.6 Australia Liquid Biopsy IVD Market Forecast 10.4 Europe Liquid Biopsy IVD Forecast by Country (2024-2029) 10.4.1 Germany Liquid Biopsy IVD Market Forecast 10.4.2 France Liquid Biopsy IVD Market Forecast 10.4.3 UK Liquid Biopsy IVD Market Forecast 10.4.4 Italy Liquid Biopsy IVD Market Forecast 10.4.5 Russia Liquid Biopsy IVD Market Forecast 10.5 Middle East & Africa Liquid Biopsy IVD Forecast by Region (2024-2029) 10.5.1 Egypt Liquid Biopsy IVD Market Forecast 10.5.2 South Africa Liquid Biopsy IVD Market Forecast 10.5.3 Israel Liquid Biopsy IVD Market Forecast 10.5.4 Turkey Liquid Biopsy IVD Market Forecast 10.5.5 GCC Countries Liquid Biopsy IVD Market Forecast 10.6 Global Liquid Biopsy IVD Forecast by Type (2024-2029) 10.7 Global Liquid Biopsy IVD Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 Bio-Rad 11.1.1 Bio-Rad Company Information 11.1.2 Bio-Rad Liquid Biopsy IVD Product Offered 11.1.3 Bio-Rad Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 Bio-Rad Main Business Overview 11.1.5 Bio-Rad Latest Developments 11.2 Roche 11.2.1 Roche Company Information 11.2.2 Roche Liquid Biopsy IVD Product Offered 11.2.3 Roche Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 Roche Main Business Overview 11.2.5 Roche Latest Developments 11.3 Biocartis 11.3.1 Biocartis Company Information 11.3.2 Biocartis Liquid Biopsy IVD Product Offered 11.3.3 Biocartis Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 Biocartis Main Business Overview 11.3.5 Biocartis Latest Developments 11.4 Qiagen 11.4.1 Qiagen Company Information 11.4.2 Qiagen Liquid Biopsy IVD Product Offered 11.4.3 Qiagen Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 Qiagen Main Business Overview 11.4.5 Qiagen Latest Developments 11.5 Guardant Health 11.5.1 Guardant Health Company Information 11.5.2 Guardant Health Liquid Biopsy IVD Product Offered 11.5.3 Guardant Health Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 Guardant Health Main Business Overview 11.5.5 Guardant Health Latest Developments 11.6 MDxHealth 11.6.1 MDxHealth Company Information 11.6.2 MDxHealth Liquid Biopsy IVD Product Offered 11.6.3 MDxHealth Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 MDxHealth Main Business Overview 11.6.5 MDxHealth Latest Developments 11.7 OME Care 11.7.1 OME Care Company Information 11.7.2 OME Care Liquid Biopsy IVD Product Offered 11.7.3 OME Care Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 OME Care Main Business Overview 11.7.5 OME Care Latest Developments 11.8 NeoGenomics Laboraories 11.8.1 NeoGenomics Laboraories Company Information 11.8.2 NeoGenomics Laboraories Liquid Biopsy IVD Product Offered 11.8.3 NeoGenomics Laboraories Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2018-2023) 11.8.4 NeoGenomics Laboraories Main Business Overview 11.8.5 NeoGenomics Laboraories Latest Developments 11.9 Sysmex Inostics 11.9.1 Sysmex Inostics Company Information 11.9.2 Sysmex Inostics Liquid Biopsy IVD Product Offered 11.9.3 Sysmex Inostics Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2018-2023) 11.9.4 Sysmex Inostics Main Business Overview 11.9.5 Sysmex Inostics Latest Developments 11.10 Menarini Silicon Biosystems 11.10.1 Menarini Silicon Biosystems Company Information 11.10.2 Menarini Silicon Biosystems Liquid Biopsy IVD Product Offered 11.10.3 Menarini Silicon Biosystems Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2018-2023) 11.10.4 Menarini Silicon Biosystems Main Business Overview 11.10.5 Menarini Silicon Biosystems Latest Developments 11.11 Adaptive Biotechnologies 11.11.1 Adaptive Biotechnologies Company Information 11.11.2 Adaptive Biotechnologies Liquid Biopsy IVD Product Offered 11.11.3 Adaptive Biotechnologies Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2018-2023) 11.11.4 Adaptive Biotechnologies Main Business Overview 11.11.5 Adaptive Biotechnologies Latest Developments 11.12 Biocept 11.12.1 Biocept Company Information 11.12.2 Biocept Liquid Biopsy IVD Product Offered 11.12.3 Biocept Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2018-2023) 11.12.4 Biocept Main Business Overview 11.12.5 Biocept Latest Developments 11.13 Angle plc 11.13.1 Angle plc Company Information 11.13.2 Angle plc Liquid Biopsy IVD Product Offered 11.13.3 Angle plc Liquid Biopsy IVD Revenue, Gross Margin and Market Share (2018-2023) 11.13.4 Angle plc Main Business Overview 11.13.5 Angle plc Latest Developments 12 Research Findings and Conclusion